Range Low Price High Price Comment
30 days $1.71 $3.40 Tuesday, 30th Apr 2024 ESPR stock ended at $1.97. This is 1.01% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $1.94 to a day high of $2.04.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
Apr 30, 2024 $1.96 $2.04 $1.94 $1.97 2 331 469
Apr 29, 2024 $1.93 $2.02 $1.88 $1.99 3 852 618
Apr 26, 2024 $2.01 $2.01 $1.88 $1.90 4 177 908
Apr 25, 2024 $2.10 $2.10 $1.95 $1.99 5 053 303
Apr 24, 2024 $2.11 $2.16 $2.06 $2.13 5 362 183
Apr 23, 2024 $1.93 $2.13 $1.93 $2.09 4 928 175
Apr 22, 2024 $1.97 $1.97 $1.84 $1.91 4 502 128
Apr 19, 2024 $1.78 $1.97 $1.71 $1.95 7 335 592
Apr 18, 2024 $1.86 $2.03 $1.81 $1.87 6 001 030
Apr 17, 2024 $1.91 $1.96 $1.81 $1.84 3 713 674
Apr 16, 2024 $1.91 $1.99 $1.84 $1.91 6 169 639
Apr 15, 2024 $2.12 $2.13 $1.93 $1.94 6 803 379
Apr 12, 2024 $2.33 $2.42 $2.04 $2.14 7 503 540
Apr 11, 2024 $2.47 $2.54 $2.25 $2.31 8 711 554
Apr 10, 2024 $2.72 $2.72 $2.45 $2.52 8 933 811
Apr 09, 2024 $3.00 $3.17 $2.76 $2.79 5 545 897
Apr 08, 2024 $3.40 $3.40 $2.90 $3.03 7 884 395
Apr 05, 2024 $3.17 $3.40 $3.02 $3.24 10 362 115
Apr 04, 2024 $3.29 $3.40 $3.03 $3.11 11 252 933
Apr 03, 2024 $2.95 $3.33 $2.90 $3.12 21 127 698
Apr 02, 2024 $2.80 $3.01 $2.69 $2.88 6 282 662
Apr 01, 2024 $2.70 $2.88 $2.63 $2.79 6 533 957
Mar 28, 2024 $2.63 $2.80 $2.54 $2.68 8 161 413
Mar 27, 2024 $2.77 $2.80 $2.52 $2.62 7 090 372
Mar 26, 2024 $2.60 $2.96 $2.56 $2.70 14 652 617
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT